Home > Insider Trading > Filing (0001415889-24-022854)

Filing Details

Accession Number:: 0001415889-24-022854
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2024-09-04 20:42:54
Reporting Period:: 2024-07-15

Accepted Time:: 2024-09-04 20:42:54
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1730430	Kiniksa Pharmaceuticals International Plc	KNSA	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1857177	Ross Moat	23 Old Bond Street, Third Floor London X0 W1S 4PZ	Chief Commercial Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Class A Ordinary Share	Acquisiton	2024-07-15	211	$15.65	18,391	No	4	A	Direct
Class A Ordinary Share	Acquisiton	2024-09-01	4,089	$0.00	22,480	No	4	M	Direct
Class A Ordinary Share	Disposition	2024-09-01	1,393	$26.74	21,087	No	4	F	Direct
Class A Ordinary Share	Acquisiton	2024-09-02	994	$0.00	22,081	No	4	M	Direct
Class A Ordinary Share	Disposition	2024-09-02	345	$26.74	21,736	No	4	F	Direct
Class A Ordinary Share	Acquisiton	2024-09-03	14,000	$8.83	35,736	No	4	M	Direct
Class A Ordinary Share	Acquisiton	2024-09-03	29,730	$11.10	65,466	No	4	M	Direct
Class A Ordinary Share	Acquisiton	2024-09-03	24,776	$11.97	90,242	No	4	M	Direct
Class A Ordinary Share	Disposition	2024-09-03	67,346	$26.10	22,896	No	4	S	Direct
Class A Ordinary Share	Disposition	2024-09-03	1,160	$27.12	21,736	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	A	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	F	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Class A Ordinary Share	Restricted Share Unit	Acquisiton	2024-09-01	6,962	$0.00	6,962	$0.00
Class A Ordinary Share	Share Option	Acquisiton	2024-09-01	36,100	$0.00	36,100	$26.74
Class A Ordinary Share	Restricted Share Unit	Disposition	2024-09-01	2,477	$0.00	2,477	$0.00
Class A Ordinary Share	Restricted Share Unit	Disposition	2024-09-01	1,612	$0.00	1,612	$0.00
Class A Ordinary Share	Restricted Share Unit	Disposition	2024-09-02	994	$0.00	994	$0.00
Class A Ordinary Share	Share Option	Disposition	2024-09-03	14,000	$0.00	14,000	$8.83
Class A Ordinary Share	Share Option	Disposition	2024-09-03	29,730	$0.00	29,730	$11.10
Class A Ordinary Share	Share Option	Disposition	2024-09-03	24,776	$0.00	24,776	$11.97

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
6,962		No	4	A	Direct
36,100	2034-08-31	No	4	A	Direct
4,954		No	4	M	Direct
4,833		No	4	M	Direct
994		No	4	M	Direct
0	2029-09-16	No	4	M	Direct
18,534	2032-04-06	No	4	M	Direct
30,924	2032-08-31	No	4	M	Direct

Footnotes

The reporting person is voluntarily reporting the acquisition of these shares pursuant to the Issuer's 2018 Employee Share Purchase Plan for the purchase period of January 16, 2024 to July 15, 2024. The acquisition of such shares was exempt pursuant to Rule 16b-3(c).
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Ordinary Share of the Issuer.
This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 3, 2024
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $25.88 to $26.80. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $26.995 to $27.18. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the grant date September 1, 2024.
The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2024.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2022.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of grant, September 1, 2023.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the vesting commencement date September 2, 2021.
The option is fully vested and exercisable.
The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is April 7, 2022.
The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2022.